Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 15675962)

1.

Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.

Busam KJ, Zhao H, Coit DG, Kucukgol D, Jungbluth AA, Nobrega J, Viale A.

J Invest Dermatol. 2005 Feb;124(2):412-8.

2.

Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.

de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, Gomes MM.

Am J Dermatopathol. 2008 Jun;30(3):207-15. doi: 10.1097/DAD.0b013e3181716e6b.

PMID:
18496419
3.

Cutaneous desmoplastic melanoma.

Busam KJ.

Adv Anat Pathol. 2005 Mar;12(2):92-102. Review.

PMID:
15731577
4.

Clusterin expression in primary and metastatic melanoma.

Busam KJ, Kucukgol D, Eastlake-Wade S, Frosina D, Delgado R, Jungbluth AA.

J Cutan Pathol. 2006 Sep;33(9):619-23.

PMID:
16965336
5.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

6.

Novel genes associated with malignant melanoma but not benign melanocytic lesions.

Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y.

Clin Cancer Res. 2005 Oct 15;11(20):7234-42.

7.

Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma.

Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Coit DG, Gyorki DE, Linehan DC, Brady MS.

Ann Surg Oncol. 2005 Mar;12(3):207-13. Epub 2005 Mar 3.

PMID:
15827812
8.

Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors.

Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG, Brady MS.

Am J Surg Pathol. 2004 Nov;28(11):1518-25.

PMID:
15489657
9.

Desmoplastic melanoma.

Busam KJ.

Clin Lab Med. 2011 Jun;31(2):321-30. doi: 10.1016/j.cll.2011.03.009. Review.

PMID:
21549245
10.

Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma.

Murali R, Loughman NT, McKenzie PR, Watson GF, Thompson JF, Scolyer RA.

Am J Clin Pathol. 2008 Nov;130(5):715-23. doi: 10.1309/AJCPG4QZHLWFXMFJ.

11.

Desmoplastic melanoma: a diagnostic trap for the unwary.

McCarthy SW, Scolyer RA, Palmer AA.

Pathology. 2004 Oct;36(5):445-51. Review.

PMID:
15370114
12.

Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.

Winnepenninckx V, van den Oord JJ.

Expert Rev Anticancer Ther. 2007 Nov;7(11):1611-31. Review.

PMID:
18020928
13.

Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.

Pryor JG, Brown-Kipphut BA, Iqbal A, Scott GA.

Am J Dermatopathol. 2011 Dec;33(8):780-5. doi: 10.1097/DAD.0b013e31820dfcbf.

PMID:
21785329
14.

Biology of desmoplastic melanoma: a case-control comparison with other melanomas.

Livestro DP, Muzikansky A, Kaine EM, Flotte TJ, Sober AJ, Mihm MC Jr, Michaelson JS, Cosimi AB, Tanabe KK.

J Clin Oncol. 2005 Sep 20;23(27):6739-46.

15.

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN.

J Clin Oncol. 2003 May 1;21(9):1775-81.

PMID:
12721254
16.

Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.

Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE.

Cancer. 2006 Feb 15;106(4):900-6.

17.

Gene expression profiling of primary cutaneous melanoma.

Winnepenninckx V, Van den Oord JJ.

Verh K Acad Geneeskd Belg. 2007;69(1):23-45. Review.

PMID:
17427873
18.

Desmoplastic melanoma with sarcomatoid dedifferentiation.

Kiuru M, McDermott G, Berger M, Halpern AC, Busam KJ.

Am J Surg Pathol. 2014 Jun;38(6):864-70. doi: 10.1097/PAS.0000000000000201.

PMID:
24618614
19.

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.

Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G.

Clin Cancer Res. 2005 Mar 1;11(5):1835-41.

20.

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI.

Ann Surg Oncol. 2007 Apr;14(4):1416-23. Epub 2006 Dec 30.

PMID:
17195911
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk